Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.
MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23
The scale uses a rational, structured and consistent approach to derive a relative ranking of the magnitude of clinically meaningful benefit that can be expected from anti-cancer treatments.
Access the ESMO-Scorecards by using the online filter, which allows you to filter either by Agent, Tumour or Score giving priority to different criteria such as Agent and Tumour Type and Tumour sub-type and Tumour sub-group in the Curative or Non-curative setting.
The latest news about ESMO Guidelines with MCBS grading.
Check out the forms and instructions for both versions of the scale and download them for your easy use!
The ESMO-MCBS is an important first step to the critical public policy issue of value in cancer care, helping to frame the appropriate use of limited public and personal resources to deliver cost effective and affordable cancer care.
The ESMO-MCBS is a dynamic tool and its criteria are revised on a regular basis.
For more information on the scale check our factsheet and booklet!
Fortunato Ciardiello, Elisabeth de Vries, Josep Tabernero and Alexandru Eniu introduce the ESMO-MCBS and its importance.
Over the years, the scale has been presented on several occasions at the ESMO Congresses.
The ESMO-MCBS Working Group is committed in maintaining and updating the scale
This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.
For more detailed information on the cookies we use, please check our Privacy Policy.
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and can only be disabled by changing your browser preferences.
